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MutagenicityWhile the role of various processes in inﬂammatory-related degenerative disorders is still being researched,
many avenues of research have concentrated on the treatment and/or prevention of these disorders.
Inﬂammatory-responses, the cholinergic system and oxidative stress have often been linked to the symptoms
prevalent in aged persons and Alzheimer's patients. The current research explored the selective inhibition of
cyclooxygenase (COX) enzymes, antioxidant and anti-cholinesterase activities of selected South African
orchid extracts, currently traded in herbalmarkets along the east coast of South Africa. Out of a total of 53 eval-
uated extracts, signiﬁcant anti-inﬂammatory activity was observed in nearly 40% of extracts in the COX-1
assay and 25% of extracts in the COX-2 assay. Overall, the DCM root extract of Ansellia africana was the most
potent, the DCM tuber extract of Eulophia hereroensiswas the only extract to signiﬁcantly inhibit both COX en-
zymes, while all Bulbophyllum scaberulum organic root extracts exhibited COX-2 selective inhibitory activity.
Bulbophyllum scaberulum DCM root extract was also themost effective anti-cholinesterase extract, performing
better than galanthamine. In the single electron transfer (SET) (2,2′-diphenylpicrylhydrazyl (DPPH) free rad-
ical scavenging assay and ferric reducing antioxidant power (FRAP) reaction based assays, E. petersii
pseudobulb and A. africana root extracts performed better than other extracts. In the hydrogen atom transfer
(HAT) (β-carotene/linoleic acid assay) reaction-based assay, the leaf extract of Tridactyle tridentata and root
extracts of Cyrtorchis arcuata and E. hereroensis exhibited the best antioxidant effects. The mutagenicity
(Salmonella/microsome assay) was also determined. Organic leaf and root extracts of C. arcuata produced
no genotoxic effects in comparison to the other tested species. None of the crude extracts tested demonstrated
mutagenic effects using S. typhimurium strain TA98 with metabolic activation. The results obtained in this
study validate the use of certain orchid species in South African traditional medicine for inﬂammation-
related degenerative disorders.
© 2013 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
Since the detection of prostaglandins (PGEs) in the brain, the func-
tion, distribution and expression of all constituents including cyclooxy-
genase (COX) enzymes in the inﬂammatory process have been
researched (Kaufmann et al., 1997). While a more comprehensive un-
derstanding is needed, the role of anti-inﬂammatory agents in the pre-
vention or treatment of Alzheimer's has been the focus of current
research (Moore and O'Banion, 2002). According to Rich et al. (1995)
and DeKosky (2003) certain non-steroidal anti-inﬂammatory drugs
(NSAIDs) when administered over a long time exhibited a decreased
risk of Alzheimer's. The varying effects of different classes of anti-tal, Pietermaritzburg, School of
evelopment, Private Bag X01,
y Elsevier B.V. All rights reserved.inﬂammatory agents in different trials suggest the use of anti-
inﬂammatories as a preventative measure and not as a treatment
(DeKosky, 2003). Montine et al. (1999) demonstrated that while COX
activity in persons susceptible to Alzheimer's was comparable to that
of control persons; concentration levels of PGE2 in cerebrospinal ﬂuid
of susceptible patients had increased ﬁve times. Their study demon-
strated the potential of COX-inhibitors in the treatment of Alzheimer's.
By selectively inhibiting the inducible COX-2, one could possibly pro-
duce an efﬁcient and tolerable anti-inﬂammatory regime that could be
used to treat symptoms of common inﬂammatory disorders such as
pain and fever; and that could be used to prevent the onset and/or
treat symptoms of diseases affecting the CNS.
According to Borovikova et al. (2000) there is an established link
between the cholinergic system and inﬂammation, with acetylcholine
(ACh) playing a role in cytokine release. Tabet (2006) reported on
evidence that acetylcholinesterase (AChE) inhibitors have an anti-
inﬂammatory role by indirectly increasing the production of antioxi-
dants in the brain, thereby acting against free radicals, amyloid toxicity
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in the brain and blood. Oxidative stress has been associated with sev-
eral degenerative disorders; which include cancer, arteriosclerosis,
inﬂammatory disorders and neurodegenerative diseases. Processes
such as lipid peroxidation have been implicated in neurodegenerative
diseases such as Alzheimer's (Markesbury and Carney, 1999). The age-
ing process has also been associated with oxidative stress (Markesbury
and Carney, 1999). Tabet (2006) also suggested that the anti-
inﬂammatory action of antioxidant compounds has a positive effect in
Alzheimer's patients. Selkoe (2005) suggested the use of antioxidants
and free radical scavengers as possible treatment options for certain
features of Alzheimer's.
Natural plant products have been used as poultices and/or anti-
inﬂammatories and as antioxidants for years. Bohlin (1995) listedﬂavo-
noids, naphthoquinones, alkylamides, phenolic phenyl-propane deriva-
tives, among others, as those compounds responsible for COX inhibition
in certain natural products. In the southernAfrican region approximate-
ly 494 orchid species occupy restricted distribution ranges, with 75%
endemism. From the literature, it has been ascertained that approxi-
mately 14 South African orchid species from 7 genera are used for
medicinal purposes in the practice of South African traditionalmedicine
(Chinsamy et al., 2011). Following the review which revealed the
pharmacological potential for South African medicinal orchid species,
this research article demonstrates the mutagenicity and validity of me-
dicinal use of certain South African orchid species for inﬂammatory-
related degenerative disorders.
2. Materials and methods
2.1. Plant selection and extract preparation
Various plant parts of seven indigenous orchid species; Ansellia
africana Lindl. (MC 01NU), Bulbophyllum scaberulum (Rolfe) Bolus
(MC 02NU), Cyrtorchis arcuata (Lindl.) Schltr. (MC 03NU), Eulophia
hereroensis Schltr. (MC 04NU), Eulophia petersii (Rchb.f.) Rchb.f.
(MC 05NU), Polystachya pubescens (Lindl.) Rchb.f. (MC 06NU) and
Tridactyle tridentata (Harv.) Schltr. (MC 07NU) were purchased
from herbal markets in Nongoma, Pietermaritzburg and Umlazi
(KwaZulu-Natal, South Africa). Voucher specimens were deposited
at the University of KwaZulu-Natal Herbarium. All plant material
was dried at 37 °C for 72 h, milled into ﬁne powders through a
1 mm ring sieve (Ultra-Centrifugal Mill ZM 200, Retsch®, Germany)
and stored in airtight containers in the dark at room temperature.
For extraction solvents; petroleum ether (PE), dichloromethane
(DCM), ethanol (EtOH) and water were used in a sequential extrac-
tion process. In order of increasing polarity, 5 g powdered plant
material were extracted in 100–200 ml cold solvent, sonicated
for 1 h in an ultrasonic water bath (Julabo GMBH, West Germany),
left to saturate overnight, and then ﬁltered under vacuum using
Whatman No. 1 ﬁlter paper. Resultant organic and aqueous extracts
was concentrated using a rotary evaporator (Büchi, Germany) at
30 °C and a freeze-drier respectively.
2.2. Anti-inﬂammatory evaluation
An enzyme-based cyclooxygenase assay (COX-1 and COX-2) as de-
scribed by Jäger et al. (1996) and Eldeen and Van Staden (2008) was
performed. Plant extracts were tested at a concentration of 250 μg/ml
per test solution. Indomethacin (Sigma-Aldrich, USA) (5 μM for COX-1
and 200 μM for COX-2) served as a positive control, while background
samples with inactivated enzymes before adding [14C] arachidonic
acid (16 mCi/mmol; 3.0 μM) and a solvent blank (EtOH) served as neg-
ative controls. Each assay was repeated three times with a duplicate set
of samples per assay. The anti-inﬂammatory effect of the plant extracts,
that is: percentage inhibition of prostaglandin synthesis, was deter-
mined by comparing the amounts of radioactivity (disintegrations perminute (DPM)) in a solvent blank to those of the samples. Inhibition
was indicated by a decline in PGE2 formation. This was calculated
using the following formula:
Cyclooxygenase Inhibition %ð Þ
¼ 1− DPMsample−DPMbackground
DPMsolvent blank−DPMbackground
 !" #
 100
where DPMsample DPMbackground and DPMsolvent blank is the radioactivity
for plant extracts, inactivated enzyme sample and EtOH sample respec-
tively. The EC50 (mg/ml) of extracts considered signiﬁcantly activewere
also determined using extracts within a range of 250–4.625 μg/ml using
a two-fold serial dilution.
2.3. Acetylcholinesterase (AChE) enzyme inhibitory activity
2.3.1. Reagents for the AChE assay
Acetylcholinesterase enzyme activity was measured by spectropho-
tometric observation of the increase in a yellow colour produced from
thiocholine when it reacts with the dithiobisnitrobenzoate ion. Three
buffers (Buffer A: 50 mM Tris–HCl, pH 8; Buffer B: 0.5 g (0.1%) bovine
serum albumin (BSA) in 500 ml Buffer A; Buffer C: 2.92 g NaCl and
2.03 g MgCl2·6H2O in 500 ml Buffer A) were prepared with Millipore
water. The substrate acetylthiocholine iodide (ATCI), 5,5′-dithiobis-(2-
nitrobenzoic acid) (DTNB) or Ellman's reagent, enzyme AChE (isolated
from electric eel- type VI-S lypophilized powder) and galanthamine
were purchased from Sigma-Aldrich.
2.3.2. The microplate assay for acetylcholinesterase inhibition
The capacity of crude orchid extracts to inhibit AChE enzyme was
determined using the protocol outlined in Ellman et al. (1961). Using
a 96-well microtitre plate on ice, samples (25 μl, 10 mg/ml) and the sol-
vent blankmethanolwere added in triplicate to the lastwell and serially
diluted in a 2-fold dilution up the plate. The effective concentration of
samples ranged between 0.03 and 1.0 mg/ml. Positive control,
galanthamine (20 μM, 50 μl) was also prepared in a 2-fold serial dilu-
tion up the plate. To this 25 μl of substrate ATCI (15 mM), 125 μl of
DTNB Ellman's reagent (3 mM in Buffer C) and 50 μl of Buffer B were
added in sequence to all wells. The absorbance of the reaction mixture
was read at 405 nm every 45 s using an ELISA microplate reader
(Opsys MR™, Dynex Technologies Inc.). Each plate was read three
times to obtain a stable background or baseline value, after which,
25 μl of AChE enzyme (0.2 U/ml in Buffer A) was added to each well.
The absorbance was read once again at 405 nm at 45 s intervals, ﬁve
times. The effect of spontaneous hydrolysis of the substrate was
corrected by subtracting the rate of reaction before adding the enzyme
from the rate after the addition. Percentage inhibition of the enzyme
AChE by each sample was calculated using the formula:
Inhibition %ð Þ ¼ 1− Reaction ratesample
Reaction rateblank
  
 100
2.4. Antioxidant evaluation
The free radical scavenging antioxidant activity of crude orchid ex-
tracts were determined using the protocol outlined in Karioti et al.
(2004) with slight modiﬁcations. The 2,2′-diphenylpicrylhydrazyl
(DPPH) free radical scavenging assay is based on a single electron trans-
fer (SET) reaction-based assay. The DPPH radical used in this assay is a
substrate that can be reduced to DPPH-H by antioxidants that have
the ability to donate a hydrogen atom to the DPPH radical. Methanolic
plant samples were prepared at different concentrations (0.065–
50 mg/ml). Each sample (15 μl) was diluted with 735 μl methanol, to
which 750 μl of a methanolic DPPH solution (0.1 mM) (Sharma and
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fective concentration of DPPH in the assay was 50 μM. A separate set of
samples, referred to as correction factor solutions, were prepared with-
out themethanolic DPPH solution (DPPH solution was substituted with
methanol). Two antioxidants, ascorbic acid and BHT, were prepared as
the positive controls (5–80 μM). Methanol served as the negative con-
trol. All reaction vessels were incubated for 30 min at room tempera-
ture in the dark. The absorbance of each sample was measured
spectrophotometrically at 517 nm (Varian Cary 50, Australia). The per-
centage free radical scavenging activity (RSA) of crude plant extracts
was calculated according to the formula:
RSA %ð Þ ¼ 100 1− AE
AD
 
where, AE is the absorbance of plant extracts and/or standard antioxi-
dants prepared without the DPPH solution subtracted from the absor-
bance value of corresponding samples prepared with DPPH solution
and; AD is the absorbance value of the negative control.
The β-carotene-linoleic bioassay explores the antioxidant capacity
of a compound by testing its ability to donate electrons with the
resulting peroxyl radical. The capacity of crude methanolic orchid ex-
tracts to prevent or reduce the coupled oxidation of β-carotene and
linoleic acid in an emulsiﬁed aqueous system (Pajero et al., 2002) was
determined using the protocol outlined by Amarowicz et al. (2004)
with modiﬁcations. The entire assay was carried out under green light
conditions as β-carotene is light sensitive. β-carotene (10 mg) was dis-
solved in 10 ml of chloroform to give a ﬁnal concentration of 0.1 g/ml in
a brown Schott bottle. Excess chloroform was evaporated under vacu-
um, leaving a thin ﬁlm of β-carotene, to which 200 μl of linoleic acid
and 2 ml of polyoxyethylene sorbitan monolaurate (Tween 20) were
added. The total volume was made up to 500 ml with aerated distilled
water with the ﬁnal concentration of β-carotene being 20 μg/ml. The
mixturewas saturated with oxygen by vigorous agitation to form an or-
ange emulsion. The β-carotene emulsion (4.8 ml) was dispensed into
glass test tubes, followed by 200 μl of either plant samples or positive
control BHT (6.25 mg/ml). The effective concentration of samples and
positive control was 250 μg/ml in the reaction mixtures. The negative
control consisted of 50%methanol. Each sample was prepared and test-
ed in triplicate. The absorbance of each reaction mixture was measured
(t = 0) at 470 nm using a spectrophotometer (Varian Cary 50,
Australia) after which, reaction vessels were incubated for 2 h at 50 °C
in the dark. The absorbance of each reaction mixture was measured
every 30 min during the incubation period at 470 nm. Tween 20 was
used to blank the spectrophotometer.
Antioxidant activitieswere expressed as average antioxidant activity
(%ANT) and oxidation rate ratio (ORR). The rate of β-carotene bleaching
was calculated according to ﬁrst order kinetics using the formula:
Rate of β‐carotene bleaching ¼ Ln At¼0
At¼t
  
 1=t ð1Þ
where At=0 is the absorbance of the emulsion at 0 min; and At = t is the
absorbance at time t (30, 60, 90 min). The average rate of β-carotene
bleachingwas calculated based on rates at 30, 60 and 90 min. The calcu-
lated average rates were used to determine the %ANT of the respective
extracts, and expressed as percent inhibition of the rate of β-carotene
bleaching in relation to the negative control using the formula:
% ANT ¼
Rcontrol−Rsample
 
Rcontrol
 100 ð2Þ
where Rcontrol and Rsample represent the respective average β-carotene
bleaching rates for the standard antioxidant and plant extracts,respectively. Antioxidant activity was further expressed as the ORR
based on the formula:
ORR ¼ Rsample
Rcontrol
: ð3Þ
The ferric reducing power assay (FRAP) outlined by Lim et al. (2009)
was used to determine the ability of crude plant extracts to reduce the
Fe3+/ferricyanide complex to the ferrous (Fe2+) form. Using a 96 well
microtitre plate, 30 μl of methanolic plant extract (6.25 mg/ml), ascor-
bic acid (0.8 mM) or BHT (0.5 mM) was serially diluted in 30 μl of
Millipore water. Thereafter, 40 μl of 0.2 M phosphate buffer (pH 7.2)
and 40 μl of potassium ferricyanide (1% w/v in potassium phosphate
buffer)were added consecutively to eachwell. Test solutionswere incu-
bated for 20 min at 50 °C; followed by the addition of trichloroacetic
acid (40 μl, 10% w/v), distilled water (150 μl) and ferric chloride
(30 μl, 0.1%w/v in potassium phosphate buffer). Sampleswere incubat-
ed for a further 30 min at room temperature in thedark. The absorbance
was read at 630 nm using a spectrophotometer (Varian Cary 50,
Australia); where an increase in absorbance indicated a greater reduc-
ing power. Samples were prepared and tested in triplicate.
2.5. Ames salmonella/microsome mutagenicity assay (Ames test)
The in vitromutagenicity assaywas carried out using three histidine-
deﬁcient (his−) Salmonella typhimurium bacterial strains TA98, TA100
and TA102 (Maron and Ames, 1983). Overnight cultures of each strain,
representing different mutations, were incubated in Oxoid nutrient
broth No. 2 on an orbital shaker over a 16 h period at 37 °C to produce
a density of 2×109 colony forming units (CFU/ml). A dilution series
of the crude plant extracts (50, 500 and 5000 μg/ml) was prepared
by re-suspending extracts in 10% DMSO. A positive control, 4-
nitroquinoline-1-oxide (4NQO), was prepared from a stock solution of
2 mg/ml to a concentration of 2 μg/ml.
Using aseptic techniques throughout the assay, 100 μl of each test
solution (sample and control solutions) were dispensed into culture
tubes, followed by 500 μl of sodium phosphate buffer (0.1 M pH 7.4).
Following a 3 min incubation period, 100 μl of overnight bacterial cul-
tures (2 × 108 cell/ml (CFU/ml) was added to each tube. Thereafter,
10 ml of 0.5 mM histidine/biotin solution was added to the liquid top
agar to produce an enriched agar; of which 2 ml was added to each
test solution. The test solution was then poured over the surface of
labelled minimal glucose agar plates and incubated (inverted in the
dark) at 37 °C for 48 h. For the experimentwith S9metabolic activation,
a freshly prepared S9 mixture containing 5% (v/v) S9 fraction sourced
from Sprague–Dawley male rats (Sigma-Aldrich, Co., St Louis) in
mixed enzymic cofactors with NADP was kept on ice and was used in
place of the phosphate buffer (500 μl) mentioned in the above experi-
ment. The positive control 2-aminoanthracene (2AA) (2 μg/ml) was
used. At the end of the incubation period, the number of revertant colo-
nies was counted using an electronic counter.
A crude extract was considered to bemutagenic if the number or re-
vertant colonies were twice the number found in the negative controls
and showed a dose-dependent curve. The mutagenic index (MI) was
also determined; where a MI ≥ 2 and a dose-dependent response
were considered mutagenic (Varella et al., 2004).
The EC50 for each sample was determined from a logarithmic
non-linear regression curve using GraphPad Prism software version
4.03 (GraphPad Software, Inc., San Diego, USA). A one-way analysis
of variance (ANOVA) and Duncan Multiple Range Test of mean ±
standard error of mean (SEM) was used to determine differences
and signiﬁcant differences among means; using SPSS software ver-
sion 10 (SPSS Inc., Chicago, USA). P = 0.05 indicated signiﬁcantly
different samples.
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3.1. Cyclooxygenase enzyme inhibition
Anti-inﬂammatory activity above 70% was considered signiﬁcant
(Taylor and Van Staden, 2001). Out of a total of 53 evaluated extracts,
21 and 13 extracts exhibited signiﬁcant anti-inﬂammatory activity in
the COX-1 and COX-2 assays respectively (Table 1). All aqueous ex-
tracts, except that of A. africana roots and B. scaberulum pseudobulbs,
showed poor or no COX-1 and COX-2 inhibition. The DCM tuber extract
of E. hereroensis was the only extract to signiﬁcantly inhibit both
COX enzymes, 100.02 ± 0.11% and 87.97 ± 8.38% respectively. All
B. scaberulum organic root extracts exhibited COX-2 selective inhibitory
activity.Table 1
Percentage inhibition of cyclooxygenase (COX)-1 and 2 enzymes by crude organic and aqueou
Species Plant part Extracti
Ansellia africana Leaves PE
DCM
Ethanol
Water
Stems PE
DCM
Ethanol
Water
Roots PE
DCM
Ethanol
Water
Bulbophyllum scaberulum Leaves Water
Pseudobulbs Water
Roots DCM
Ethanol
Water
Cyrtorchis arcuata Leaves Ethanol
Water
Roots Ethanol
Water
Eulophia hereroensis Tubers PE
DCM
Ethanol
Water
Roots DCM
Ethanol
Water
Eulophia petersii Leaves PE
DCM
Ethanol
Water
Stems PE
DCM
Ethanol
Water
Pseudobulbs PE
DCM
Ethanol
Water
Roots PE
DCM
Ethanol
Water
Polystachya pubescens Pseudobulbs DCM
Ethanol
Water
Roots Ethanol
Tridactyle tridentata Leaves Water
Roots DCM
Ethanol
Water
Values are themean (±) standard deviation (n = 3). ND—not determined. Anti-inﬂammatory
70% was considered signiﬁcant (Taylor and Van Staden, 2001); values in bold indicate those exThe EC50 of crude orchid extracts against COX-1 and COX-2 is pre-
sented in Table 2. Based on the anti-inﬂammatory activity presented in
Table 1, the EC50 of 14 crude extracts were determined in the COX-1
assay; and six crude extracts were determined in the COX-2 assay. Over-
all, the DCM root extract of A. africanawas found to be the most potent
extract (0.25 ± 0.10 mg/ml). This extract was the most potent extract
in the COX-1 assay, while the 80% EtOH root extract of B. scaberulum
was the most potent in the COX-2 assay (0.44 ± 0.32 mg/ml).
3.2. Anti-cholinesterase activity
The AChE inhibitory activity of different crude extracts of seven
orchid species is presented in Table 3. Generally it was the root extracts
which exhibited greater AChE inhibitory activity. The lowest EC50 values extracts of seven indigenous South African orchids at 250 μg/ml.
on solvent Percent inhibition (%)
COX-1 COX-2
ND 66.03 ± 13.64
ND 57.48 ± 20.80
104.11 ± 1.62 0.00 ± 0.00
30.66 ± 9.75 19.51 ± 4.73
ND 83.38 ± 3.16
106.11 ± 1.29 78.52 ± 0.97
43.99 ± 3.46 0.00 ± 0.00
7.91 ± 6.05 0.00 ± 0.00
ND 16.08 ± 11.03
99.36 ± 1.35 17.21 ± 1.50
100.15 ± 0.36 0.00 ± 0.00
71.15 ± 0.37 51.56 ± 3.78
ND 32.81 ± 2.14
ND 79.86. ± 10.70
17.73 ± 0.39 100.06 ± 0.01
18.12 ± 3.08 93.31 ± 2.33
5.02 ± 11.53 58.09 ± 3.25
89.19 ± 0.18 76.75 ± 11.02
44.80 ± 8.04 ND
94.05 ± 5.67 72.26 ± 3.35
54.02 ± 0.95 ND
ND 98.39 ± 6.04
100.02 ± 0.11 87.97 ± 8.38
0.00 ± 0.00 5.89 ± 3.32
18.70 ± 3.05 0.00 ± 0.00
84.78 ± 3.19 73.54 ± 2.27
60.82 ± 0.89 54.19 ± 0.00
0.00 ± 0.00 0.00 ± 0.00
109.88 ±1.48 27.30 ± 9.78
ND 22.16 ± 13.85
74.71 ± 9.98 74.27 ± 10.14
0.00 ± 0.00 0.00 ±0.00
107.22 ± 0.94 32.89 ± 6.13
106.35 ± 4.39 56.24 ± 3.93
4.96 ± 13.82 18.03 ± 0.62
37.60 ± 12.30 39.85 ± 1.97
96.94 ± 3.22 10.71 ± 0.00
106.49 ± 2.94 64.69 ± 8.03
89.23 ± 9.23 17.43 ± 11.89
34.80 ± 3.92 0.00 ± 0.00
100.83 ± 0.93 77.29 ± 3.02
109.65 ± 0.00 84.17 ± 4.83
99.72 ± 2.43 28.57 ± 12.33
10.16 ± 12.50 0.00 ± 0.00
ND 24.91 ± 0.86
55.26 ± 2.59 0.00 ± 0.00
0.00 ± 0.00 15.05 ± 8.06
30.16 ± 2.67 25.51 ± 7.43
4.56 ± 1.02 33.06 ± 6.20
100.18 ± 0.25 65.07 ± 1.29
89.64 ± 1.16 46.27 ± 21.05
26.24 ± 24.52 14.63 ± 2.81
activity below 20%was considered insigniﬁcant, 20–40% low, 40–70%moderate and above
tracts where an EC50 was determined.
Table 2
Estimated EC50 (mg/ml) for cyclooxygenase (COX)-1 and 2 inhibition of crude organic
extracts of ﬁve South African orchids.
Species Plant part Extraction
solvent
EC50 (mg/ml)
COX-1 COX-2
Ansellia africana Leaves Ethanol 1.64 ± 0.25cd ND
Stems PE ND 1.50 ± 0.15a
DCM 1.77 ±0.09d ND
Roots DCM 0.25 ±0.10a ND
Ethanol 0.42 ± 0.09ab ND
Bulbophyllum
scaberulum
Roots DCM ND 1.43 ± 0.86a
Ethanol ND 0.44 ± 0.32a
Eulophia hereroensis Tubers PE ND 1.12 ± 0.33a
DCM 0.87 ± 0.28abc 1.17 ± 0.15a
Eulophia petersii Leaves PE 1.32 ± 0.18cd ND
Stems PE 2.79 ± 0.04e 7.91 ± 1.11b
DCM 1.49 ± 0.05cd ND
Pseudobulbs PE 0.99 ± 0.51abcd ND
DCM 0.87 ± 0.12abc ND
Roots PE 1.17 ± 0.06bcd ND
DCM 1.41 ± 0.64cd ND
Ethanol 0.99 ± 0.38abcd ND
Tridactyle tridentata Roots DCM 1.47 ± 0.89cd ND
Values are the mean (±) standard deviation (n = 3). ND—not determined. Different
letters represent signiﬁcant differences between EC50 means for each enzyme (same
column), P = 0.05. Values in bold indicate the most potent anti-inﬂammatory extracts.
Table 3
Acetylcholinesterase inhibitory activity (EC50) of crude extracts of seven indigenous South
African orchids.
Species Plant part Extraction
solvent
EC50 (mg/ml)
Ansellia africana Leaves PE 2.19 ± 0.83jk
DCM 0.44 ± 0.02abc
Ethanol 0.47 ± 0.22abcd
Stems PE 1.86 ± 0.12ij
DCM 0.50 ± 0.10abcde
Ethanol 0.95 ± 0.04bcdefgh
Roots PE 0.33 ± 0.03ab
DCM 0.34 ± 0.14ab
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The most active extract of A. africana was the EtOH root extract. For
C. arcuata the aqueous root extract proved to be the most potent. The
most effective extracts of E. hereroensis and E. petersii were the EtOH
root and DCM stem extracts respectively. The DCM root extract was
the most potent extract for P. pubescens, while the most active extract
of T. tridentata was the EtOH root extract.Ethanol 0.24 ± 0.03ab
Bulbophyllum scaberulum Roots DCM 0.02 ± 0.00a
Ethanol 0.26 ± 0.007ab
Cyrtorchis arcuata Leaves DCM 1.89 ± 0.19jk
Ethanol 0.55 ± 0.03abcde
Water 0.72 ± 0.07abcdef
Roots PE 2.21 ± 0.16jk
DCM 1.77 ± 0.41ij
Ethanol 0.84 ± 0.07bcdefgh
Water 0.47 ± 0.04abcd
Eulophia hereroensis Tubers PE 1.20 ± 0.24cdefghi
DCM 0.23 ± 0.16ab
Ethanol 0.68 ± 0.06abcdef
Roots DCM 0.29 ± 0.05ab
Ethanol 0.23 ± 0.07ab
Eulophia petersii Leaves PE 2.72 ± 0.01k
DCM 0.56 ± 0.004abcde
Ethanol 1.57 ± 0.17hij
Stems PE 0.56 ± 0.16abcde
DCM 0.39 ± 0.04ab
Ethanol 1.20 ± 0.19defghi
Pseudobulbs PE 1.32 ± 0.07fghi
DCM 0.51 ± 0.14abcde
Ethanol 1.37 ± 0.23fghi
Roots PE 2.22 ± 0.62jk
DCM 0.51 ± 0.05abcde
Ethanol 1.47 ± 0.12ghi
Polystachya pubescens Pseudobulbs PE 0.48 ± 0.21abcd
DCM 0.95 ± 0.04bcdefgh
Ethanol 1.24 ± 0.23efghi
Roots DCM 0.27 ± 0.02ab
Ethanol 0.78 ± 0.05abcdefg
Tridactyle tridentata Roots DCM 0.30 ± 0.03ab
Ethanol 0.25 ± 0.07ab
Water 0.46 ± 0.01abcd
Values are the mean (±) standard deviation (n = 3); Different letters represent
signiﬁcant differences between EC50 means, P = 0.05, and EC50 values in bold indicate
those extracts with most signiﬁcant AChE inhibitory activity. EC50 value of galanthamine
(0.44 ±0.10 μM).3.3. Antioxidant activities
Percentage free radical scavenging activity of crude orchid extracts
were measured in the DPPH radical scavenging assay. While the princi-
ple of the assay does not stipulate the meaning of negative percentage
radical scavenging activity the use of a wide range of concentrations en-
sured the determination of an EC50 value. There was a dose-dependent
change in radical scavenging activities of crude extracts from which
EC50 values were determined. In terms of EC50, the methanolic root ex-
tracts of all species, except that of E. petersii, had consistently more ef-
fective radical scavenging activity than that of other plant parts within
each species. The methanolic pseudobulb extract of E. petersii, was the
most potent extract (1.32 ± 0.86 mg/ml).
The antioxidant activity of crude orchid extracts as measured in the
β-carotene-linoleic acid assay is presented in Table 4. Beta carotene
bleaching occurs because of oxidation of linoleic acid; this coupled
oxidation was observed by a decrease in absorbance over time.
Based on ORR, the leaf extract of T. tridentata and the root extracts of
C. arcuata and E. hereroensis exhibited the best antioxidant effects
(0.02, 0.023 and –0.15 respectively). Similarly, the %ANT of these
samples was greater than that of BHT (95.88 ± 6.90%) and all
other samples. Eight out of a total of 18 samples exhibited a greater
capacity to prevent β-carotene oxidation in the assay when compared
to BHT.
Fig. 1 presents the antioxidant activity of crude orchid extracts as
measured in the ferric reducing power assay. All crude orchid extracts
tested demonstrated a general dose-dependent response; where an
increase in extract concentration resulted in an increased reducing
power activity. The reducing power of ascorbic acid (0.08 mM) and
BHT (0.05 mM), as measured as absorbance, was 1.12 ± 0.12 and
0.73 ± 0.08 respectively. At 6.25 mg/ml, methanolic A. africana rootand E. petersii pseudobulb extracts were the most effective in reducing
power activity.
3.4. Mutagenic effects
Table 5 presents the average number of induced revertant colonies,
the standard deviation and the MI at different concentrations (5, 0.5,
0.05 mg/ml) of crude orchid extracts using three S. typhimurium strains
(TA98, TA100 and TA102). A crude extract was considered to be muta-
genic if the number or revertant colonies were twice the number found
in the negative controls and showed a dose-dependent response.
Mutagenic extracts were observed for the TA98 strain only. All con-
centrations of A. africana DCM leaf and stem extracts tested, the DCM
root extract (5, 0.5 mg/ml) and EtOH leaf, stem and root extracts
at 5 mg/ml exhibited mutagenic effects. The EtOH root extracts (5,
0.5 mg/ml) of B. scaberulum exhibited mutagenic indices comparable
to that of 4NQO (17.00 and 13.00, respectively). Eulophia petersii PE
pseudobulb extract demonstrated mutagenic potential at the highest
concentration tested (5 mg/ml). The EtOH root extracts of T. tridentata
showed mutagenic effects at 0.5 and 0.05 mg/ml.
Table 4
Percent inhibition ofβ-carotene bleachingby crudemethanol extracts of seven indigenous
South African orchids.
Species Plant part ORR % ANT
Ansellia africana Leaves 0.42 ± 0.31a 87.87 ± 2.74bc
Stems 0.31 ± 0.01a 90.61 ± 5.25bc
Roots ND ND
Bulbophyllum scaberulum Leaves 0.20 ± 0.61a 100.00 ± 55.61cd
Pseudobulbs 0.1 ± 0.001a 100.00 ± 5.23cd
Roots 1.22 ± 1.37b 100.00 ± 1.33cd
Cyrtorchis arcuata Leaves 0.35 ± 0.49a 29.45 ± 4.22a
Roots 0.023 ± 0.04a 100.00 ± 10.48cd
Eulophia hereroensis Tubers 0.63 ± 0.44ab 63.96 ± 22.98b
Roots 0.00a 100.00 ± 8.41cd
Eulophia petersii Leaves 0.31 ± 0.18a 84.96 ± 3.10bc
Stems 0.28 ± 0.02a 92.18 ± 2.10bc
Pseudobulbs 0.22 ± 0.07a 98.62 ± 0.50bcd
Roots 0.19 ± 0.10a 92.42 ± 0.001bc
Polystachya pubescens Pseudobulbs 0.28 ± 0.14a 92.75 ± 2.78bc
Roots 0.23 ± 0.09a 90.12 ± 2.89bc
Tridactyle tridentata Leaves 0.02 ± 0.18a 100.00 ± 25.74d
Roots 0.10 ± 0.01a 96.66 ± 1.00bcd
Values are the mean (±) standard error (n = 2); EC50 values in bold indicate those
extracts with most signiﬁcant antioxidant activity. ORR = Average β-carotene bleaching
rates as compared to the negative control and %ANT = average antioxidant activity; and
%ANT for BHT (95.88 ± 6.90%). Different letters in each column represent signiﬁcant
differences between means, P = 0.05
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nies, the standard deviation and the MI at different concentrations
(5, 0.5, 0.05 mg/ml) of crude orchid extracts using S. typhimurium
strain TA98 with metabolic activation. A crude extract was consid-
ered to be mutagenic if the number of revertant colonies were
twice the number found in the negative controls and showed a
dose-dependent response. None of the extracts tested demonstrated
mutagenic effects.4. Discussion
The effectiveness of anti-inﬂammatory and antioxidant drugs
in treating inﬂammatory and neurodegenerative disorders has been
widely documented (Houghton et al., 2007; Howes and Houghton,
2003). The current study demonstrated the anti-inﬂammatory, antioxi-
dant and AChE inhibitory activities of various crude orchid extracts.
Approximately ﬁve species of South African orchids are used to treat
inﬂammatory conditions. Polystachya ottoniana is used to soothe pain
experienced in teething babies and to treat diarrhoea. A. africana is ad-
ministered as an antimicrobial while Eulophia species such as Eulophia
cucullata and Eulophia ovalis, are used primarily to relieve pain. The cur-
rent investigation included research of C. arcuata (treatment of diabetes
and skin infections) and T. tridentata (treatment of psychological disor-
ders such as madness). Two orchid species, B. scaberulum and
E. hereroensis, not mentioned in literature previously used in South
African traditionalmedicinewere also included as theywere being trad-
ed in the abovementioned herbal markets.
Orchid extracts that displayed signiﬁcant effects in anti-inﬂammatory,
antioxidant and AChE inhibitory assays may be potential natural plant
product targets in the treatment of inﬂammatory and neurodegenera-
tive disorders. Extracts include: A. africana EtOH root, B. scaberulum
DCM root, C. arcuata methanolic root, E. hereroensis DCM tuber,
E. petersii DCM stem and T. tridentata DCM root extracts. The EtOH
root extract of B. scaberulum exhibited the most potent selective inhib-
itory effect on COX-2 (Table 2). While the DCM tuber extract of
E. hereroensis, was the only extract to signiﬁcantly inhibit both COX
enzymes (Table 2). Preliminary tests suggest signiﬁcantly higher levels
of gallotannin content in A. africana, and E. hereroensis methanol root
extracts. This may account for the signiﬁcant anti-inﬂammatory activi-
ty. Similarly, the presence of condensed tannins in E. hereroensis rootand B. scaberulum stem/root extracts may explain the observed anti-
inﬂammatory effects.
The potent anti-inﬂammatory and antioxidant effect of E. hereroensis
and E. petersii supports the use of species from this genus for
inﬂammatory-related symptoms in South African traditional medicine.
The overall %ANT of P. pubescens pseudobulb and root extracts was great-
er than 90%, which might validate the use of species from this genus as
substitutes to P. ottoniana, to treat certain inﬂammatory disorders. Flavo-
noids in the pseudobulbs and roots of P. pubescensmay have contributed
to the antioxidant effects. During the survey of leaf ﬂavonoid content in
Orchidaceae, Williams (1979) isolated xanthones, mangiferin and
isomangiferin from ﬁve species of Polystachya andMaxillaria. The author
also observed that there was no pattern of ﬂavonoid distribution within
the family Orchidaceae, and geographical location played a signiﬁcant
role in the presence of ﬂavonoid compounds (Williams, 1979). All four
species that did register some ﬂavonoid content in preliminary studies,
shared similar distribution ranges; and are all epiphytic species. Plant
compounds such as ﬂavonoids, naphthoquinones, alkylamides and phe-
nolic phenyl-propane derivatives represent the usual compounds found
in certain natural products that are responsible for COX inhibition
(Bohlin, 1995). The presence of ﬂavonoids in B. scaberulum and
T. tridentata may explain the potent activity observed in the anti-
inﬂammatory and AChE inhibitory assays. The medicinal value of ﬂavo-
noids includes anti-inﬂammatory, antifungal, antioxidant activities and
wound healing. The wound healing efﬁcacy of Oncidium ﬂexuosum, an
epiphytic orchid used in Brazilian traditional medicine for inﬂammation
and wounds, was attributed to the presence of ﬂavonoids and tannins
(De Gaspi et al., 2011).
Imbricatin, a stilbenoid isolated previously from Bulbophyllum
and other orchid genera, was one of three isolated stilbenoids recom-
mended for use as skin photoprotectants based on antioxidant, anti-
inﬂammatory and immunomodulatory effects (Simmler et al., 2010).
The Bulbophyllum and Eulophia genera are not only traded in South
African herbal markets for medicinal uses, they also feature in a list of
21 genera listed in Ayurvedic literature as being used for medicines
(Singh et al., 2007). The medicinal usefulness of the Bulbophyllum and
Eulophia genera is supported by the pharmacological and phytochemi-
cal assessment of the genus Vanda which also features on this list of
common medicinal plant sources in Indian traditional medicine (Singh
et al., 2007). Simmler et al. (2010) evaluated the skin photoprotective
effect of Vanda coerulea stilbenoids based on the widespread use of or-
chid extracts in the cosmetic industry. Ultraviolet-induced damage
often results in oxidative stress and associated inﬂammatory processes.
Ultraviolet B (UVB) radiation is known to increase PGE2 production (due
to the upregulation of COX-2 expression) and ROS; resulting in skin in-
ﬂammation. Simmler et al. (2010) mention natural photoprotective
polyphenol compounds such as proanthocyanidins and resveratrol
with proven antioxidant and related anti-inﬂammatory activities.
Stem methanolic solutions of isolated stilbenoids from V. coerulea per-
formed better than “hydro-alcoholic” solutions in the in vitro DPPH/O
radical scavenging and Parameter™ PGE-2 enzyme immunological
assays. Further chemical analysis of South African Bulbophyllum and
Eulophia species may reveal related chemical compounds with compa-
rable results.
When testing methanolic crude extracts in two different SET
reaction-based assays, the E. petersii pseudobulb extract was the most
potent radical scavenging extract (Fig. 1). Alternatively, when using
the β-carotene-linoleic acid assay, a HAT reaction-based assay, the
ORR revealed the leaf extract of T. tridentata and the root extracts of
C. arcuata and E. hereroensis to have the best antioxidant effects
(Table 4). Similarly, the overall %ANT of these three samples to prevent
the coupled oxidation of β-carotene and linoleic acid were greater than
that of BHT and all other samples. The total phenolic content of
E. hereroensis pseudobulb extractsmay contribute to the antioxidant ac-
tivity; while the presence of ﬂavonoids in the leaf and root extracts of
T. tridentata and C. arcuata, respectively, may play a role in the
Fig. 1. Ferric reducing capacity of methanolic extracts from seven indigenous South
African orchids.
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native mechanism may have been affected due to the presence of the
ﬂavonoids in these extracts.
The medicinal uses of C. arcuata (treatment of diabetes and skin
infections) and T. tridentata (treatment of psychological disorders
such as madness) may be validated based on their signiﬁcant anti-
inﬂammatory and antioxidant effects (Tables 1, 2, 5) (Bulpitt, 2005).
The anti-inﬂammatory and antioxidant activities demonstrated in this
investigationmay suggest cellular and neuroprotective effects. Different
classes of well-established anti-inﬂammatories have been shown to
exhibit varied effects in patients with neuroinﬂammatory disorders
such as Alzheimer's. With prolonged use, other NSAIDs have demon-
strated a positive response (DeKosky, 2003). Such varied responses to
anti-inﬂammatory drugs, is indicative of alternative neuroprotective
pathways other than COX-inhibition (Stuchbury and Münch, 2005).
This observation, and the potential of COX-inhibitors in treatment of
Alzheimer's, is further supported by the report of Montine et al.
(1999) where COX activity in persons susceptible to Alzheimer's was
comparable to that of control persons; while concentration levels of
PGE2 in cerebrospinal ﬂuid of susceptible patients had increased ﬁve
times. Cyrtochis arcuata and T. tridentata also share a similar distribution
pattern, whichmay result in the accumulation of similar bioactive com-
pounds and account for the comparable antioxidant effects. The use of
the same vernacular name for C. arcuata, various Eulophia species and
Tridactyle species, may be explained by their comparable positive anti-
inﬂammatory and antioxidant effects in this investigation.
Based on the assumption that users of traditional medicine would
consume an aqueous concoction of plant material, aqueous extracts
were expected to exhibit signiﬁcant biological activity. Instead, all
aqueous extracts, except that of A. africana roots and B. scaberulum
pseudobulbs, showed poor or no COX-1 and COX-2 inhibition
(Table 1). Higher levels of activity were achieved with the organic
extracts (PE, DCM and EtOH) (Table 1). Root extracts of B. scaberulum
exhibited the most potent selective inhibitory effect on COX-2
(Table 2) and interestingly, the DCM root extract was also the most
effective crude orchid extract to inhibit AChE; performing better than
the commercial product galanthamine (Table 3). Natural plant constitu-
ents such as polyphenols, saponins, certain pigments and even fatty
acids are often extracted when using non-polar solvents (Lower,
1985). The EtOH extract of Gastrodia elata, traditionally used to treat
inﬂammatory disorders such as rheumatism, demonstrated potent
anti-angiogenic effects in the CAM assay; while the n-butanol fraction
showed dose-dependent activity. In vivo vascular permeability, an early
sign of inﬂammatory response, was signiﬁcantly inhibited; while strong
analgesic and anti-inﬂammatory activitywas observed. Ahn et al. (2007)
postulated that such activity was a result of inhibited NO production
and COX-2 expression. Compounds such as 4-hydroxybenzyl alcohol
and 4-hydroxybenzaldehyde, isolates of G. elata, were thought to be
responsible for the anti-inﬂammatory effects (Ahn et al., 2007).
Researchers, looking for compounds with more extensive biological
activities, produced a new class of active and selective AChE inhibi-
tors by introducing amino acid moieties into the backbone of 4-
hydroxybenzaldehyde. The resultant compounds exhibited more
potent AChE inhibitory activity. Two compounds 4b (IC50 0.19 μM)
and 4i (IC50 0.28 μM) performed better than galanthamine (IC50
0.55 μM); and 4i was selective for AChE (Wen et al., 2007).
Alternatively, traditional healersmay be using hot water extracts (as
opposed to our cold water extracts); a procedure that could possibly
extract the less water-soluble compounds when using water as the
extractant. Primary metabolites such as carbohydrates are commonly
extracted with water (Zha et al., 2007). Cyrtopodium cardiochilum (CC)
hot water pseudobulb extract produced the CC polysaccharide. It was
found to signiﬁcantly increase the phagocytic index when compared
to the standard (Zymosan) and exhibited a similar signiﬁcant anti-
inﬂammatory effect when compared to Indomethacin (10 mg/kg body
weight). Where an increase in vascular permeability is one of the
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pressed this response by approximately 20% of the control (Barreto
and Parente, 2006).
Mainly due to safety concerns in pharmaceutical and food industries,
mutagenicity assessment programmes have increased dramatically.
There are two major concerns regarding mutagens, these are: their
ability either to induce cancer or to affect the germ line and future gen-
erations. In industry the Salmonellamutagenicity (Ames) test,whichde-
tects gene mutations (Verschaeve et al., 2004), is used extensively as a
preliminary indicator to identify possible carcinogens and/or the muta-
genic potential of crude plant extracts and clinical drugs. However, not
all cancer causing substances show positive results in the Ames test. A
positive result indicates the ability of a substance to produce a change
in DNA structure; that is, gene point mutations or the gain or loss of
whole chromosomes. However, further analysis is required to deter-
mine the carcinogenic potential of the substance. Elgorashi et al.
(2003) reported on the possible mutagenic effects of 51 South AfricanTable 5
Mutagenicity of crude orchid extracts as determined in the Salmonella/microsome assay (witho
Species Plant part Extraction
solvent
Concentration
(μg/ml)
Salmonella typhimu
TA98
Revertants
per plate
Ansellia africana Leaves DCM 5000 47.34 ± 12.3
500 36.67 ± 7.1
50 32.67 ± 1.9
Ethanol 5000 25.34 ± 10.4
500 20.17 ± 4.9
50 12.67 ± 1.2
Stem DCM 5000 41.00 ± 6.6
500 26.00 ± 1.4
50 34.00 ± 6.1
Ethanol 5000 27.00 ± 9.9
500 22.84 ± 6.8
50 18.17 ± 1.2
Root DCM 5000 36.50 ± 12.02
500 31.50 ± 9.19
50 22.50 ± 3.54
Ethanol 5000 31.50 ± 9.19
500 ND
50 ND
Bulbophyllum
scaberulum
Root DCM 5000 20.50 ± 6.36
500 18.50 ± 9.19
50 18.00 ± 9.90
Ethanol 5000 204.00 ± 31.1
500 156.00 ± 28.28
50 11.50 ± 4.95
Cyrtorchis arcuata Leaf PE 5000 18.00 ± 4.24
500 15.50 ± 7.78
50 13.50 ± 0.71
DCM 5000 16.00 ± 5.66
500 11.50 ± 4.95
50 11.00 ± 5.66
Ethanol 5000 9.00 ± 5.66
500 7.50 ± 0.71
50 12.50 ± 2.12
Roots DCM 5000 7.50 ± 6.36
500 8.50 ± 0.71
50 13.00 ± 1.41
Ethanol 5000 9.00 ± 2.83
500 11.50 ± 2.12
50 13.50 ± 4.95
Eulophia hereroensis Tuber Ethanol 5000 15.00 ± 4.24
500 14.50 ± 2.12
50 15.50 ± 4.95
Roots DCM 5000 11.50 ± 0.71
500 15.00 ± 2.82
50 18.00 ± 0.00
Ethanol 5000 17.50 ± 2.12
500 11.00 ± 1.41
50 14.00 ± 5.66medicinal plant species. Reid et al. (2006) evaluated 42 other South
African species. There has been extensive research into the mutagenic
and anti-mutagenic potential of medicinal plants used in the South
African traditional medical system (Elgorashi et al., 2002).
Medicinal orchids were selected on the basis of their ethnobotanical
use and availability. A plant extract was considered mutagenic when a
MI of ≥2 for any concentration of that extract was observed; together
with a dose-dependent response (Vargas et al., 1993). An increase in
number of His+ revertant colonies over the negative control indicated
genotoxic effects. The Ames assay revealed that mutagenic extracts
were observed for the TA98 strain only. Without metabolic activation,
certain organic extracts of A. africana leaf, stem and root extract at var-
ious concentrations tested (0.5 and 0.05 mg/ml) exhibited genotoxic ef-
fects; while the EtOH root extracts (5 and 0.5 mg/ml) of B. scaberulum
exhibited mutagenic indices comparable to that of 4NQO. Bioactive
E. petersii PE pseudobulb extract demonstrated mutagenic potential at
the highest concentration tested (5 mg/ml). The EtOH root extracts ofutmetabolic activation) expressed as average revertants per plate andmutagenicity index.
rium strains
TA100 TA102
Mutagenicity
index
Revertants
per plate
Mutagenicity
index
Revertants
per plate
Mutagenicity
index
3.95 174.00 ± 19.80 1.66 656.00 ± 67.88 1.57
3.06 158.00 ± 8.49 1.50 354.00 ± 76.37 0.85
2.72 162.00 ± 14.15 1.54 476.00 ± 28.28 1.14
2.11 112.00 ± 0.00 1.07 430.00 ± 36.77 1.03
1.68 84.00 ± 1.10 0.80 414.00 ± 25.46 0.99
1.06 106.00 ± 36.77 1.01 512.00 ± 11.31 1.22
3.42 68.00 ± 5.66 0.65 572.00 ± 30.55 1.37
2.17 120.00 ± 28.28 1.14 322.00 ± 14.14 0.77
2.83 140.00 ± 28.28 1.33 396.00 ± 56.57 0.95
2.25 154.00 ± 25.46 1.47 560.00 ± 27.72 1.34
1.90 122.00 ± 48.08 1.16 ND ND
1.51 114.00 ± 2.83 1.09 560.00 ± 14.00 1.34
3.04 146.00 ± 19.80 1.39 428.00 ± 11.31 1.02
2.63 118.00 ± 14.14 1.12 420.00 ± 152.7 1.00
1.88 106.00 ± 31.11 1.01 338.00 ± 127.3 0.81
2.63 154.00 ± 19.80 1.47 360.00 ± 16.97 0.86
ND 146.00 ± 2.82 1.39 ND ND
ND 110.00 ± 19.80 1.05 ND ND
1.71 143.00 ± 9.90 1.36 175.50 ± 6.36 0.42
1.54 101.00 ± 4.24 0.96 253.50 ± 0.71 0.61
1.50 127.00 ± 7.07 1.21 280.50 ± 17.68 0.67
17.00 118.00 ± 4.95 1.12 189.00 ± 26.87 0.45
13.00 ND ND 184.00 ± 8.49 0.44
0.96 ND ND 199.00 ± 4.24 0.48
1.50 168.00 ± 5.66 1.60 226.00 ± 42.43 0.54
1.29 154.00 ± 8.49 1.47 274.00 ± 70.71 0.66
1.13 116.00 ± 5.66 1.10 350.00 ± 59.40 0.84
1.33 146.00 ± 14.14 1.39 342.00 ± 53.74 0.82
0.96 130.00 ± 2.82 1.24 318.00 ± 121.6 0.76
0.92 128.00 ± 33.94 1.22 358.00 ± 36.77 0.86
0.75 154.00 ± 19.80 1.47 352.00 ± 28.28 0.84
0.63 160.00 ± 62.23 1.52 288.00 ± 22.63 0.69
1.04 166.00 ± 25.46 1.58 338.00 ± 19.80 0.81
0.63 122.00 ± 8.46 1.16 390.00 ± 98.99 0.93
0.71 72.00 ± 11.31 0.69 410.00 ± 65.05 0.98
1.08 148.00 ± 0.00 1.41 330.00 ± 70.71 0.79
0.75 128.00 ± 16.97 1.22 186.00 ± 36.77 0.44
0.96 124.00 ± 22.63 1.18 248.00 ± 33.94 0.59
1.13 120.00 ± 11.31 1.14 358.00 ± 25.46 0.86
1.25 132.00 ± 4.24 1.26 226.00 ± 22.63 0.54
1.21 89.00 ± 0.00 0.85 217.50 ± 45.96 0.52
1.29 124.00 ± 9.90 1.18 301.00 ± 24.04 0.72
0.96 116.00 ± 22.63 1.10 ND ND
1.25 98.00 ± 8.49 0.93 387.00 ± 21.21 0.93
1.50 140.00 ± 0.00 1.33 384.00 ± 50.91 0.92
1.46 147.00 ± 31.11 1.40 347.50 ± 28.99 0.83
0.92 124.50 ± 0.71 1.19 322.00 ± 15.56 0.77
1.17 119.00 ± 12.73 1.13 329.50 ± 43.13 0.79
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Table 5 (continued)
Species Plant part Extraction
solvent
Concentration
(μg/ml)
Salmonella typhimurium strains
TA98 TA100 TA102
Revertants
per plate
Mutagenicity
index
Revertants
per plate
Mutagenicity
index
Revertants
per plate
Mutagenicity
index
Eulophia petersii Leaf DCM 5000 22.00 ± 0.00 1.83 ND ND 540.00 ± 5.66 1.29
500 26.00 ± 0.00 2.17 ND ND 342.00 ± 104.7 0.82
50 ND ND ND ND 422.00 ± 127.3 1.01
Ethanol 5000 14.00 ± 4.24 1.17 118.00 ± 19.80 1.12 242.00 ± 25.46 0.58
500 9.00 ± 1.41 0.75 168.00 ± 5.66 1.60 326.00 ± 8.49 0.78
50 11.00 ± 5.66 0.92 120.00 ± 11.31 1.14 324.00 ± 0.00 0.78
Stem DCM 5000 14.50 ± 0.71 1.21 170.00 ± 25.46 1.62 234.00 ± 42.43 0.56
500 21.50 ± 2.12 1.79 164.00 ± 11.31 1.56 460.00 ± 164.1 1.10
50 15.00 ± 5.66 1.25 140.00 ± 0.00 1.33 368.00 ± 33.94 0.88
Ethanol 5000 18.50 ± 9.19 1.54 106.00 ± 14.14 1.01 624.00 ± 11.31 1.49
500 19.50 ± 3.54 1.63 160.00 ± 0.00 1.52 716.00 ± 175.4 1.71
50 15.00 ± 4.24 1.25 116.00 ± 22.63 1.10 492.00 ± 22.63 1.18
Pseudobulb PE 5000 26.00 ± 4.24 2.17 ND ND 434.00 ± 53.74 1.04
500 19.50 ± 0.71 1.63 ND ND 308.00 ± 62.23 0.74
50 16.00 ± 2.82 1.33 ND ND 418.00 ± 132.9 1.00
DCM 5000 13.00 ± 2.82 1.08 116.00 ± 0.00 1.10 206.00 ± 14.14 0.49
500 16.50 ± 3.54 1.38 88.00 ± 0.00 0.84 390.00 ± 76.37 0.93
50 9.00 ± 2.82 0.75 124.00 ± 5.66 1.18 404.00 ± 164.1 0.97
Ethanol 5000 21.50 ± 0.71 1.79 156.00 ± 5.66 1.49 370.00 ± 116.0 0.89
500 17.50 ± 4.95 1.46 168.00 ± 10.61 1.60 340.00 ± 22.63 0.81
50 15.00 ± 1.41 1.25 144.00 ± 39.60 1.37 274.00 ± 8.49 0.66
Root DCM 5000 15.50 ± 0.71 1.29 116.00 ± 50.91 1.10 483.00 ± 26.87 1.16
500 11.50 ± 6.36 0.96 146.00 ± 8.49 1.39 194.00 ± 42.43 0.46
50 16.00 ± 1.41 1.33 134.00 ± 42.43 1.28 322.00 ± 76.37 0.77
Ethanol 5000 14.50 ± 0.71 1.21 94.00 ± 14.14 0.90 340.00 ± 28.28 0.81
500 16.50 ± 2.12 1.38 152.00 ± 62.23 1.45 322.00 ± 48.08 0.77
50 16.00 ± 1.41 1.33 148.00 ± 45.26 1.41 236.00 ± 45.25 0.56
Polystachya pubescens Pseudobulb PE 5000 11.50 ± 3.54 0.96 135.00 ± 12.73 1.29 214.50 ± 4.95 0.51
500 6.00 ± 2.82 0.50 120.00 ± 0.00 1.14 243.50 ± 16.26 0.58
50 16.50 ± 6.36 1.38 114.00 ± 28.28 1.09 228.00 ± 28.28 0.55
DCM 5000 12.00 ± 1.41 1.00 126.00 ± 42.42 1.20 127.50 ± 33.23 0.31
500 12.00 ± 4.24 1.00 112.00 ± 0.00 1.07 226.50 ± 7.78 0.54
50 9.50 ± 2.12 0.79 108.00 ± 22.63 1.03 204.50 ± 16.26 0.49
Ethanol 5000 17.00 ± 1.41 1.42 132.00 ± 50.91 1.26 184.00 ± 22.63 0.44
500 16.00 ± 1.41 1.33 204.00 ± 50.91 1.94 247.00 ± 24.04 0.59
50 18.50 ± 3.54 1.54 108.00 ± 16.97 1.03 278.00 ± 8.49 0.67
Root PE 5000 14.50 ± 9.19 1.21 123.00 ± 7.07 1.17 193.50 ± 2.12 0.46
500 15.50 ± 0.71 1.29 ND ND 240.00 ± 28.28 0.57
50 12.00 ± 5.66 1.00 120.00 ± 14.14 1.14 266.50 ± 36.06 0.64
DCM 5000 13.00 ± 5.66 1.08 ND ND 204.00 ± 16.97 0.49
500 14.00 ± 1.41 1.17 ND ND 193.50 ± 44.55 0.46
50 11.50 ± 2.12 0.96 ND ND 160.00 ± 52.33 0.38
Ethanol 5000 11.00 ± 4.24 0.92 88.00 ± 11.31 0.84 242.50 ± 2.12 0.58
500 13.00 ± 1.41 1.08 112.00 ± 5.66 1.07 228.00 ± 57.98 0.55
50 13.50 ± 0.71 1.13 90.00 ± 2.83 0.86 260.00 ± 22.63 0.62
Tridactyle tridentata Roots PE 5000 12.50 ± 0.71 1.04 143.00 ± 9.90 1.36 139.50 ± 16.26 0.33
500 15.50 ± 2.12 1.29 123.00 ± 13.44 1.17 244.00 ± 4.24 0.58
50 15.00 ± 0.00 1.25 136.00 ± 4.95 1.30 187.00 ± 21.21 0.45
DCM 5000 16.00 ± 0.00 1.33 134.00 ± 7.78 1.28 56.50 ± 4.95 0.14
500 16.00 ± 1.41 1.33 131.00 ± 3.54 1.25 164.50 ± 10.61 0.39
50 16.50 ± 2.12 1.38 131.00 ± 8.49 1.25 260.00 ± 45.26 0.62
Ethanol 5000 ND ND 132.00 ± 10.61 1.26 154.00 ± 5.66 0.37
500 94.50 ± 9.19 7.88 129.00 ± 3.54 1.23 255.00 ± 33.94 0.61
50 41.50 ± 3.54 3.46 ND ND 204.00 ± 33.94 0.49
Positive control 196.00 ± 2.83 16.33 1868.0 ± 231.9 17.79 1679.0 ± 175.4 4.02
Negative control 12.00 ± 0.71 1.00 105.00 ± 13.43 1.00 418.00 ± 11.31 1.00
Values are the mean (±) standard deviation (n = 3); values in bold indicate those extracts with most signiﬁcant mutagenic index. ND—not determined.
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bolic activation using TA98, no mutagenic effects were observed for all
crude orchid extracts tested.
The primary aim of mutagenicity testing of bioactive natural plant
extracts is to determine their safety. Based on available literature,
there are limited reports ofmutagenicity and safety testing of orchid ex-
tracts and their isolated products. Of the seven orchid species consid-
ered in this investigation, organic leaf and root extracts of C. arcuata
produced no genotoxic effects (Table 5). The extractsmay contain ﬂavo-
noids. Food derived ﬂavonols such as quercetin, kaempferol and
myricetin have been reported to affect the cell cycle and growth ofcancer cells, thereby reducing the risk of cancer (Verma et al., 1988;
Yoshida et al., 1990). The non-genotoxic effects of C. arcuata coupled
with the presence of ﬂavonoids necessitates further investigation.
Zhang et al. (2005) also established that dimerised phenanthrenes are
required to inhibit cancer cell growth. Research on compounds such
as moscatilin; with known anti-inﬂammatory, cytotoxic, anti-platelet
aggregation and anti-proliferative properties; and erianin, provide in-
sight into the mechanisms involved in cancer progression. Similary, or-
chid extracts that demonstrate signiﬁcant biological activities should be
researched further for other biological activities. The herbicidal poten-
tial of gymnopusin, a phenanthrene derivative from Maxillaria densa,
Table 6
Mutagenicity of crude orchid extracts as determined in the Salmonella/microsome assay (with metabolic activation) expressed as average revertants per plate and mutagenicity index.
Species Plant part Extraction
solvent
Concentration
(μg/ml)
Salmonella typhimurium strain (TA98)
Revertants per plate Mutagenicity index
Ansellia africana Stem DCM 5000 16.50 ± 4.95 0.67
500 12.50 ± 2.12 0.51
50 11.50 ± 2.12 0.47
Root DCM 5000 11.50 ± 3.54 0.47
500 13.00 ± 2.82 0.53
50 9.00 ± 2.82 0.37
Eulophia hereroensis Roots DCM 5000 19.00 ± 0.00 0.78
500 21.00 ± 2.82 0.86
50 25.50 ± 2.12 1.04
Ethanol 5000 11.50 ± 2.12 0.47
500 16.00 ± 2.82 0.65
50 16.50 ± 2.12 0.67
Eulophia petersii Stem DCM 5000 11.00 ± 0.00 0.45
500 14.00 ± 0.00 0.57
50 15.50 ± 0.71 0.63
Ethanol 5000 16.00 ± 8.49 0.65
500 10.50 ± 0.71 0.43
50 13.00 ± 1.41 0.53
Root DCM 5000 11.50 ± 2.12 0.47
500 18.00 ± 4.24 0.73
50 11.50 ± 2.12 0.47
Tridactyle tridentata Roots PE 5000 15.00 ± 1.41 0.61
50 18.00 ± 0.00 0.73
DCM 50 8.50 ± 6.36 0.35
Positive control 141 ± 9.19 5.76
Negative control 24.50 ± 2.12 1.00
Values are the mean (±) standard deviation (n = 3); values in bold indicate those extracts with most signiﬁcant mutagenic index.
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lian cell lines H4TG (IC50 13.0 ± 0.9 μM), MDCK (IC50 11.0 ± 0.5 μM),
NIH3T3 (IC50 12.0 ± 1.0 μM) and KA31T (IC50 21.0 ± 0.5 μM)
(Valencia-Islas et al., 2002). Collectively, such information can beneﬁt
further research efforts dealing with bioherbicides and their safety.
Conversely, extensive research has been conducted on the antitumor,
antimutagenic and anti-angiogenesis effects of orchid derived extracts
and compounds. While some cytotoxic compounds are considered a
biohazard, some compounds are often referred to as anticancer com-
pounds (Kovács et al., 2008). Antitumour activities have been detected
in the Bulbophyllum genus (Yao et al., 2005), with B. odoratissimum, in
particular, containing cytotoxic phenolics (Chen et al., 2008). A fairly
large number of phenanthrenes have been reported from the
Orchidaceae family; particularly the Dendrobium, Bulbophyllum, Eria,
Maxillaria, Bletilla, Coelogyna, Cymbidium, Ephemerantha and Epiden-
drum genera. Phenanthrenes were mainly isolated from whole plants,
cortex, tubers or stems and a large number where isolated from
Bulbophyllum vaginatum (Kovács et al., 2008). In the current study,
B. scaberulum EtOH root extracts exhibited mutagenic properties com-
parable to 4NQO (Table 5). Further chemical and pharmacological in-
vestigation of other organs of this species could reveal phenanthrenes
and antitumor properties of B. scaberulum. Taxol and vinblastine, well
known mutagens, are used as anticancer drugs. Orchid extracts that
exhibit mutagenic effects (A. africana organic leaf, stem and root,
B. scaberulum EtOH root, E. petersii PE pseudobulb and T. tridentata
EtOH root extracts) should be examined further to determine
their full potential. Such compounds may effectively treat cancers; in
addition to providing insight into the mechanisms involved in its
progression.
The toxicology and mutagenicity of medicinal plants need equal
consideration in medicinal plant research. Most of the orchid species
used for cultural practices are administered as emetics (Chinsamy
et al., 2011). It would be important to know what the effects of these
orchid-derived medicines are on the human body and more especially
their safety. Generally the results obtained in this study validate the
use of certain orchid species in South African traditional medicine for
pain-related ailments. Other pharmacological conditions linked toinﬂammation were also investigated to establish other potential activi-
ties of the medicinal plant extracts. A more comprehensive assessment
of the chemistry of South African orchids would allow one to more
conﬁdently assert a relationship between chemical proﬁles, interaction
between different classes of compounds, biological activity and inﬂu-
ence of geographical location. The results obtained in this study provide
scientiﬁc information that could aid in the isolation of potential bioac-
tive compounds with fewer side-effects.
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